Recent analyses of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) trial looked at the effects of fenofibrate on gout and cardiovascular events in patients with type 2 diabetes.
The effect of hyperglycemia on stroke risk was examined by several studies published in the past month.
One study found that personalized text messaging improved patients' self-management while another looked at the potential value of providing social comparisons to other patients' diabetes control.
Two studies compared heart failure rates in patients with and without type 2 diabetes, while a third looked at the risk of heart failure associated with various classes of glucose-lowering drugs.
One recent study examined rates of autism spectrum disorder in children in California, while another in Sweden compared birth defects in infants of mothers with type 1 diabetes and infants of mothers without diabetes.
One recent study found overtreatment of type 2 diabetes among elderly patients, while another looked at how many patients with diabetes would be referred to a liver specialist under proposed European guidelines.
The effects of adding liraglutide to insulin treatment were assessed by multiple studies published in the past month.
The American Heart Association and American Diabetes Association recently released a joint scientific statement on prevention of cardiovascular disease in adults with type 2 diabetes.
Metformin—including its use, effects, and mechanisms—was the focus of some research published in the past month.
Recent studies analyzed depression in diabetes, including associated causes of death, the potential benefits of peer support and a plant-based diet, and strategies for screening and treatment.